Baxter International (BAX) Common Equity (2009 - 2026)

Baxter International (BAX) has 18 years of Common Equity data on file, last reported at $6.0 billion in Q1 2026.

• Common Equity for Q1 2026 came in at $6.0 billion, down 14.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 billion (down 14.33% YoY), and the FY2025 annual result was $6.1 billion, down 13.13% from the prior year.
• Common Equity declined to $6.0 billion in Q1 2026 per BAX's latest filing, from $6.1 billion in the prior quarter.
• Over five years, Common Equity peaked at $9.1 billion in Q1 2022 and troughed at $5.6 billion in Q3 2022.
• A 5-year average of $7.2 billion and a median of $7.2 billion in 2025 frame the typical range for Common Equity.
• On a YoY basis, Common Equity climbed as much as 46.37% in 2023 and fell as far as 36.75% in 2023.
• A 5-year view of Common Equity shows it stood at $5.9 billion in 2022, then jumped by 43.65% to $8.5 billion in 2023, then slipped by 17.05% to $7.0 billion in 2024, then slipped by 13.13% to $6.1 billion in 2025, then slipped by 0.97% to $6.0 billion in 2026.
• Business Quant data shows BAX's Common Equity at $6.0 billion in Q1 2026, $6.1 billion in Q4 2025, and $7.2 billion in Q3 2025.